Pfizer Research Prize I The Foundation

History

Pfizer establishes the "Foundation Pfizer Research Prize" in 1991. A clear expression of Pfizer's commitment to medical research. In 1992, the foundation awarded the research prize for the first time. The objective is to promote the development of new therapeutic approaches based on pure and applied medical research.

For the first four years, the Foundation awards the research prize exclusively in the field of cardiovascular disease. In 1995, the Foundation board and the benefactors decide to expand the award to include the fields of neuroscience and neurology, infectious diseases, rheumatology and immunology. In 2008, the field of oncology was added and in 2016 the field of pediatrics.

In 2024, the 33rd award ceremony took place. In 33 years, a total of 438 scientists were awarded and received a total prize money of over 6.8 million Swiss francs. This year, we are taking the time to update the concept of one of Switzerland's best-known medical research awards. The next award ceremony will take place in 2026. All terms and conditions for submission, including deadlines, will be available on this website in due time. Applications will be called for as soon as the new modalities are determined.